Published in
Impact Journals, Oncotarget, 13(9), p. 11145-11158, 2018
DOI: 10.18632/oncotarget.24298
Links
Tools
Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma
Journal article published in 2018 by
Zuzana Macek Jilkova,
Ayca Zeybek Kuyucu,
Keerthi Kurma,
Séyédéh Tayébéh,
Séyédéh Tayébéh Ahmad Pour,
Ahmad Pour,
Gaël S. Roth 
,
Giovanni Abbadessa,
Yi Yu,
Brian Schwartz,
Nathalie Sturm,
Patrice N. Marche,
Pierre Hainaut,
Thomas Decaens
,
Giovanni Abbadessa,
Yi Yu,
Brian Schwartz,
Nathalie Sturm,
Patrice N. Marche,
Pierre Hainaut,
Thomas Decaens
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 